Bain Capital Life Sciences Investors, LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$852.7B
Holdings
35
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,831,307 | $118.9B | 13.95% | |
| 2 | DVAXDYNAVAX TECHNOLOGIES CORP | 8,415,000 | $105.9B | 12.42% | |
| 3 | PHVSPHARVARIS N V | 3,180,601 | $70.3B | 8.24% | |
| 4 | ARQTARCUTIS BIOTHERAPEUTICS INC | 3,000,000 | $63.9B | 7.50% | |
| 5 | —EQRX INC | 10,003,573 | $46.9B | 5.50% | |
| 6 | NUVLNUVALENT INC | 3,428,014 | $46.5B | 5.45% | |
| 7 | CRNXCRINETICS PHARMACEUTICALS IN | 2,305,558 | $43.0B | 5.04% | |
| 8 | —MERSANA THERAPEUTICS INC | 8,663,673 | $40.0B | 4.69% | |
| 9 | AMLXAMYLYX PHARMACEUTICALS INC | 1,948,214 | $37.5B | 4.40% | |
| 10 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $36.3B | 4.25% | |
| 11 | CARAEURCARA THERAPEUTICS INC | 2,647,473 | $24.2B | 2.83% | |
| 12 | NRIXNURIX THERAPEUTICS INC | 1,822,883 | $23.1B | 2.71% | |
| 13 | TSVT*2SEVENTY BIO INC | 1,408,901 | $18.6B | 2.18% | |
| 14 | PTGXPROTAGONIST THERAPEUTICS INC | 2,260,572 | $17.9B | 2.10% | |
| 15 | YB4PSAVARA INC | 11,622,598 | $17.7B | 2.07% | |
| 16 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $17.6B | 2.07% | |
| 17 | CCCCC4 THERAPEUTICS INC | 1,642,210 | $12.4B | 1.45% | |
| 18 | ANNXANNEXON INC | 3,241,628 | $12.2B | 1.43% | |
| 19 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $9.8B | 1.15% | |
| 20 | TNGXTANGO THERAPEUTICS INC | 1,921,790 | $8.7B | 1.02% | |
| 21 | ACADACADIA PHARMACEUTICALS INC | 600,523 | $8.5B | 0.99% | |
| 22 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $8.2B | 0.96% | |
| 23 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $6.9B | 0.81% | |
| 24 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $6.9B | 0.81% | |
| 25 | IVVDADAGIO THERAPEUTICS INC | 1,937,207 | $6.4B | 0.75% | |
| 26 | —SYROS PHARMACEUTICALS INC | 6,264,420 | $6.0B | 0.71% | |
| 27 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.4B | 0.63% | |
| 28 | —APTINYX INC | 8,891,758 | $5.0B | 0.58% | |
| 29 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $4.9B | 0.57% | |
| 30 | —PANACEA ACQUISITION CORP II | 500,000 | $4.9B | 0.57% | |
| 31 | —ARYA SCIENCES ACQUISITN CORP | 500,000 | $4.9B | 0.57% | |
| 32 | —BCLS ACQUISITION CORP | 487,500 | $4.8B | 0.57% | |
| 33 | —FRAZIER LIFESCIENCES ACQU CO | 300,000 | $3.0B | 0.35% | |
| 34 | ASNSUSDX4 PHARMACEUTICALS INC | 3,019,540 | $2.9B | 0.34% | |
| 35 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 5,347,689 | $2.7B | 0.32% |